Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
10/2002
10/03/2002WO2001027857A3 Methods for generating databases and databases for identifying polymorphic genetic markers
10/03/2002WO2001025448A9 Adenylate cyclase
10/03/2002WO2001023564A9 Secreted factors
10/03/2002WO2001021812A9 Phosphatases which activate map kinase pathways
10/03/2002WO2001021794A9 Smad associating polypeptides
10/03/2002WO2001021310A9 Device for rapid dna sample processing with integrated liquid handling, thermocycling, and purification
10/03/2002WO2001020331A9 Substrates and screening methods for transport proteins
10/03/2002WO2001020015A9 Reverse transfection method
10/03/2002WO2001019846A9 Transgenically produced fusion proteins
10/03/2002WO2001017343A9 Methods for evaluating a compound for its effect on skin
10/03/2002WO2001009177A3 Affinity fluorescent proteins and uses thereof
10/03/2002WO1999064459A3 Gene encoding organic anion transporter
10/03/2002WO1999060106A3 A universal plant promoter inducible by low- temperatures
10/03/2002US20020144310 Isolated polynucleotides and polypeptides relating to loci underlying resistance to soybean cyst nematode and soybean sudden death syndrome and methods employing same
10/03/2002US20020144309 Transgenic plants expressing MinD or MinE and an efficient method for plant chloroplast transformation and gene expression
10/03/2002US20020144308 Viral amplification of recombinant messenger RNA in transgenic plants
10/03/2002US20020144307 Plant defense-inducible genes and their use
10/03/2002US20020144306 Nucleotide sequences coding polypeptide for use in the generation of disease resistant plants
10/03/2002US20020144305 Methods and compositions to reduce or eliminate transmission of a transgene
10/03/2002US20020144304 Nucleotide sequences coding polypeptide for use in the generation of disease resistant plants
10/03/2002US20020144302 Expression vector coding protein for use in the treatment of liver disorders
10/03/2002US20020144300 Expression vector coding protein for use in the treatment of diabetes
10/03/2002US20020144299 Nuceotide sequences coding malarial surface protein for use in the treatment and prevention of malaria
10/03/2002US20020144298 Novel human genes and gene expression products
10/03/2002US20020144296 Transgenic animal for use in the generation of heterologous proteins in milk; for use in generation of disease and infection resistant pigs
10/03/2002US20020143471 Method of predicting and generating dna sequences and apparatus for carrying out the method
10/03/2002US20020143166 Method for removing a universal linker from an oligonucleotide
10/03/2002US20020143164 Ras activator nucleic acid molecules, polypeptides and methods of use
10/03/2002US20020143163 Gene conferring resistance to the antibacterial 4,5-dihydroxy-2-cyclopenten-1-one (DHCP), the protein encoded by same, and applications thereof
10/03/2002US20020143162 Methods
10/03/2002US20020143161 Members of the d52 gene family
10/03/2002US20020143159 Bone morphogenetic protein (bmp)-17 and bmp-18 compositions
10/03/2002US20020143156 Nucleotide sequences coding polypeptide for use in the diagnosis and treatment of nervous system, vision, kidney and liver disorders
10/03/2002US20020143155 Nucleotide sequences coding polypeptide for use in the treatment of inflammatory defects
10/03/2002US20020143154 Protein for use in the diagnosis and treatment of tumors
10/03/2002US20020143150 Monoclonal antibody to the clonotypic structure of a T-cell receptor, a pharmaceutical composition and a diagnostic reagent comprising the same
10/03/2002US20020143149 Seven trans-membrane receptor-Fitz2
10/03/2002US20020143148 Polypeptide for use in human therapeutics and diagnostics
10/03/2002US20020143111 High density, miniaturized arrays and methods of manufacturing same
10/03/2002US20020143110 High density, miniaturized arrays and methods of manufacturing same
10/03/2002US20020142989 Oncolytic/immunogenic complementary-adenoviral vector system
10/03/2002US20020142988 G-coupled receptor showing selective affinity for ATP
10/03/2002US20020142987 Methods of inducing mucosal immunity
10/03/2002US20020142986 Used in the diagnosis or prognosis of liver associated disorders
10/03/2002US20020142983 MUC-1 antagonists and methods of treating immune disorders
10/03/2002US20020142982 Method for regulating angiogenesis
10/03/2002US20020142980 Nucleic acid molecules with novel chemical compositions capable of modulating gene expression
10/03/2002US20020142975 Antisense inhibitor of recql4 expression
10/03/2002US20020142961 As pharmaceuticals, diagnostics, biosensors and bioreactors
10/03/2002US20020142960 Exposing cells to an aggregate formulation which comprises VP22, or a polypeptide with transport function of VP22, and oligonucleotides or polynucleotides; exposing cells to a disaggregating agent which can promote disaggregation
10/03/2002US20020142957 May be used in vaccines and drugs for prophylaxis and therapy
10/03/2002US20020142952 Polynucleotides encoding novel secreted proteins
10/03/2002US20020142949 Inducing cytotoxicity in a neoplastic cell comprising: contacting said cell with an amount of a GSSP-2 polypeptide
10/03/2002US20020142947 By muta-synthesis using a mutated micro-organism to influence the biosynthesis of at least one of the precursors of group B streptogramines; mutant strain employed is preferably derived from the strain S. pristinaespiralis SP92
10/03/2002US20020142938 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
10/03/2002US20020142916 Method for reducing pest damage to corn by treating transgenic corn seeds with clothianidin pesticide
10/03/2002US20020142468 Interfering with fungal gene expression; obtain fungal sample, incubate with modulator, monitor transcription and propagation of fungal structures
10/03/2002US20020142467 Method for culturing recombinant cells
10/03/2002US20020142465 Processing cell or viable tissue; obtain cell or viable tissue, expose to radiation from laser, monitor preferential activity in cell
10/03/2002US20020142464 Nucleotide sequences coding preferential polypeptide for use in the treatment of infections, atherosclerosis, cancer, nervous system, gastrointestinal, muscle, bone, heart, vision, kidney and urogenital disorders
10/03/2002US20020142456 Protein for use in the treatment of body weight defects
10/03/2002US20020142455 Enhanced replication of HCV RNA
10/03/2002US20020142449 Compositions and methods useful for HCV infection
10/03/2002US20020142448 Antibody for use in the diagnosis, treatment and prevention of bone disorders and cancer
10/03/2002US20020142447 DNA encoding the human serine protease EOS
10/03/2002US20020142446 DNA encoding the human serine protease EOS
10/03/2002US20020142445 Peptides for use in the treatment of tumors and graft versus host disease
10/03/2002US20020142444 AL-2 neurotrophic factor
10/03/2002US20020142442 Tumor suppressor WAF1
10/03/2002US20020142441 Compositions and methods for the treatment and diagnosis of cardiovascular disease
10/03/2002US20020142440 Peptide for use in the diagnosis and treatment of inflammation, cancer, arteriosclerosis and degenerative disorders
10/03/2002US20020142437 Nucleotide sequences coding enzymatic polypeptide for use in the treatment of respiratory system disorders
10/03/2002US20020142436 Enzymatic protein for use in the treatment of tumors, nervous system, cardiovascular, psychological, pregnancy, bone, kidney, respiratory and alimentary canal disorders
10/03/2002US20020142435 Isolated human lipase proteins, nucleic acid molecules encoding human lipase proteins, and uses thereof
10/03/2002US20020142432 Human endosulfine gene
10/03/2002US20020142430 Peptide for use in the treatment of inflammation, cancer, arteriosclerosis and psoriasis
10/03/2002US20020142429 Elongation factor-2 kinase (EF-2 kinase) and methods of use therefor
10/03/2002US20020142425 Beta 1,3-galactosyltransferase and DNA encoding the same
10/03/2002US20020142424 Protein for use as a bioluminescent signaling tool
10/03/2002US20020142422 Nucleotide sequences coding metabolic pathway protein for use in foods, feed, cosmetics and pharmaceutical
10/03/2002US20020142421 Isolated human aminoacylase, nucleic acid molecules encoding human aminoacylase, and uses thereof
10/03/2002US20020142420 Cloned leptospira outer membrane protein
10/03/2002US20020142416 Isolated human enzyme proteins, nucleic acid molecules encoding human enzyme proteins, and uses thereof
10/03/2002US20020142414 Nucleotide sequences coding polypeptide for use in the treatment of lung defects, septic shock or inflammation
10/03/2002US20020142409 Biocatalytic synthesis of quinic acid and conversion to hydroquinone
10/03/2002US20020142408 Production of cyclic terpenoids
10/03/2002US20020142406 Generating polyhydroxyalkanoates; obtain genetically cells which express enzymes associated with generation of polyhydroxyalanoates, incubate with 3-hydroxypropionate or 3-hydroxyvalerate, recover polyhydroxyalkonoates
10/03/2002US20020142405 Process for the preparation of L-amino acids by fermentation and nucleotide sequences coding for the accDA gene
10/03/2002US20020142404 Nucleotide sequences coding polypeptide for use in generation of amino acids for use in human medicine, foods, and animal nutrients
10/03/2002US20020142402 Method for synthesis of nucleic acids
10/03/2002US20020142401 Isolated gene for methylmalonyl CoA epimerase and uses thereof
10/03/2002US20020142400 Production of polyketides in bacteria and yeast
10/03/2002US20020142398 Chemokine expressed in fetal spleen, its production and uses
10/03/2002US20020142397 Genetically engineering cell; obtain cell, incubate with cell growth factor, remove nucleus or chromatin, insert into cell, propagate cell
10/03/2002US20020142394 Exonuclease-mediated gene assembly in directed evolution
10/03/2002US20020142393 Episomally replicating vector, its preparation and use
10/03/2002US20020142392 Human melanocyte stimulating hormone receptor polypeptide and DNA
10/03/2002US20020142391 Synthesis of human procollagens and collagens in recombinant DNA systems
10/03/2002US20020142390 Nitrogen transport metabolism
10/03/2002US20020142389 Soluble T cell receptor